| ¿µ¹® | rejection | ÇÑ±Û | °ÅºÎ |
|---|---|---|---|
| ¼³¸í | ¾î¶² °³Ã¼ÀÇ Á¶Á÷À» ´Ù¸¥ °³Ã¼¿¡ À̽ÄÇßÀ» ¶§ ±×°ÍÀ» ¹èÁ¦ÇÏ´Â »ýü¹ÝÀÀ. °³Ã¼°£¿¡ À̽ļö¼úÀ» Çϸé óÀ½ 7~10ÀÏ Á¤µµ´Â Ç÷¾×°ø±Þµµ ȸº¹µÇ°í º°´Ù¸¥ ÀÌ»óÀ» ¹ß°ßÇÏÁö ¸øÇÏÁö¸¸, ±× ÈÄ¿¡ ±«»ç°¡ »ý±ä´Ù. ±× ¶§¹®¿¡ Àå±âÀÌ½Ä ÈÄ¿¡ °¢Á¾ Áõ»óÀÌ ¹ß»ýÇÏ¿© À̽ļö¼úÀÌ ½ÇÆÐ·Î µ¹¾Æ°¡±â ½±´Ù. »ç¶÷ÀÇ Ã¼³»¿¡ ÀÌÁ¾ÀÇ Á¶Á÷ÀÌ µé¾î°¡¸é ±×¿¡ ´ëÇØ Ç×ü°¡ ¸¸µé¾îÁø´Ù. ÀÌ´Â Ç÷¾× ¼ÓÀÇ ¸²ÇÁ±¸°¡ ±× ÀÌÁ¾Á¶Á÷¿¡ Á¢ÃËÇÏ¿© Ȱ¼ºÈµÈ »óÅ¿¡¼ ¸²ÇÁÀý·Î µÇµ¹¾Æ¿Í¼ °Å±â¼ Ç×ü¸¦ ¸¸µå´Â °ÍÀ¸·Î »ý°¢µÇ°í ÀÖ´Ù. ÀÌ Ç×ü´Â ¼¼Æ÷¼ºÇ×ü¿Í ü¾×¼ºÇ×ü·Î ³ª´©¾îÁö¸ç ÀÌ ¾çÀÚÀÇ °øµ¿ÀÛ¿ë¿¡ ÀÇÇØ °ÅºÎ¹ÝÀÀÀÌ »ý±â´Â °ÍÀ¸·Î º¸ÀδÙ. ÀÌ´Â °³Ã¼¹æÀ§¹ÝÀÀÀ̶ó°íµµ ÇÒ ¼ö ÀÖÁö¸¸ À̽ÄÁ¶Á÷ÀÇ Ç÷°üÀº ±×°ÍµéÀÇ ÀÛ¿ëÀ¸·Î ³»ÇǼ¼Æ÷°¡ »óÇÏ¿© Ç÷ÀüÀ» Çü¼ºÇϹǷΠÇ÷ÇàÀÌ µÎÀýµÈ´Ù. ±× ¶§¹®¿¡ ±«»ç°¡ »ý±â°í ±«»çÁ¶Á÷Àº ü¿Ü·Î ¹èÃâµÈ´Ù. °ÅºÎ¹ÝÀÀÀº À̽ÄÁ÷ÈÄ¿¡ »ý±â´Â °Í, ¼öÁÖ¿¡¼ ¼ö°³¿ù ÈÄ¿¡ ºñ±³Àû ±Þ¼ºÀ¸·Î »ý±â´Â °Í, ¼ö³â ÈÄ¿¡ ¼¼È÷ »ý±â´Â °ÍÀÌ ÀÖ´Ù. Àå±â À̽Ľÿ¡´Â ÀÌ ¹ÝÀÀÀ» ¾ïÁ¦Çϱâ À§ÇØ ¸é¿ª¾ïÁ¦Á¦³ª ºÎ½Å°ÑÁúÈ£¸£¸óÀ» Åõ¿©ÇÑ´Ù. |
||
| ¿µ¹® | chronic lymphocytic leukemia | ÇÑ±Û | ¸¸¼º¸²ÇÁ¼º ¹éÇ÷º´ |
|---|---|---|---|
| ¼³¸í | ¹éÇ÷º´(leukemia)¶õ ºñÁ¤»óÀûÀÎ ¹éÇ÷±¸ ¼¼Æ÷ÀÇ Áõ½Ä¿¡ ÀÇÇØ ÀϾ´Â º´ÀûÀÎ »óŸ¦ ¸»Çϴµ¥, ÈçÈ÷ ¸»ÃÊÇ÷¾×¿¡ ¹ÌºÐȼ¼Æ÷°¡ ³ªÅ¸³ª¸ç, Á¤»óÀûÀÎ ÀûÇ÷±¸¼¼Æ÷¿Í ¹éÇ÷±¸¼¼Æ÷, Ç÷¼ÒÆÇÀÇ ±Þ°ÝÇÑ °¨¼Ò¸¦ °¡Á®¿Í Á¤»óÀûÀÎ ¼¼Æ÷¿¡ ÀÇÇØ ÇàÇØÁö´Â ¿©·¯ ±â´ÉÀÇ °¨¼Ò¸¦ ÁÖÁõ»óÀ¸·Î ÇÏ¿© º´¿ø¿¡ ã¾Æ¿À°Ô µÈ´Ù. µû¶ó¼ ÀûÇ÷±¸¼¼Æ÷ÀÇ °¨¼Ò·Î ÀÎÇÑ ºóÇ÷, ¹éÇ÷±¸¼¼Æ÷ÀÇ °¨¼Ò·Î ÀÎÇÑ ¸¹Àº °¨¿°Áõ¼¼(ÈçÈ÷ °É¸®Áö ¾Ê´Â ¼¼±Õ¿¡ ÀÇÇÑ °¨¿°, Áö³ªÄ¡°Ô ÀæÀº °¨±â, Æó·Å µî), Ç÷¼ÒÆÇ¼¼Æ÷ÀÇ °¨¼Ò·Î ÀÎÇÑ ÃâÇ÷Áõ»óÀÌ ³ªÅ¸³´Ù. ¶ÇÇÑ ÇǸ¦ »ý»êÇÏ´Â °ñ¼ö Á¶Á÷¿¡¼´Â ÀÌ·± ºñÁ¤»óÀûÀÎ ¼¼Æ÷ÀÇ Áõ½Ä¸¸À» º¼ ¼ö ÀÖÀ¸¸ç, Á¤»óÀûÀÎ ¼¼Æ÷ÀÇ Áõ½ÄÀº º¸±â Èûµé´Ù. ¸¸¼º¸²ÇÁ¼º ¹éÇ÷º´Àº ¼¾ç¿¡¼´Â ºñ±³Àû ¹éÇ÷º´ Áß¿¡¼ ÈçÇÑ ÇüÀÌÁö¸¸ µ¿¾ç±Ç¿¡¼´Â ¾ÆÁÖ µå¹® ¹éÇ÷º´ÀÇ ÇüÅÂÀÌ´Ù. ´ë°³ 60¼¼ ÀÌ»óÀÇ °í·ÉÃþ¿¡¼ ¸¹ÀÌ »ý±â°í 30¼¼ ÀÌÇÏ¿¡¼´Â °ÅÀÇ Ã£¾Æº¼ ¼ö°¡ ¾ø´Ù. Ç÷¾×°Ë»ç»ó¿¡¼ ¸²ÇÁ±¸ÀÇ ¸¹Àº Áõ°¡¸¦ º¼ ¼ö°¡ ÀÖ°í, ´ë½Å¿¡ ´Ù¸¥ Ç÷¾×¼¼Æ÷µéÀº °¨¼Ò¸¦ ³ªÅ¸³½´Ù. ¹éÇ÷º´ Áß ¿¹Èİ¡ ÁÁÀº ÆíÀÌ¸ç ´ë°³ Ä¡·á´Â Ç×¾ÏÁ¦¸¦ ÀÌ¿ëÇÑ ÈÇпä¹ýÀ» ¸¹ÀÌ »ç¿ëÇϸç, Æò±Õ »ýÁ¸±â°£Àº 4~5³âÀÌ´Ù. |
||
| ¿µ¹® | chronic obstructive pulmonary disease | ÇÑ±Û | ¸¸¼ºÆó¼âÆóº´ |
|---|---|---|---|
| ¼³¸í | ¸¸¼ºÀûÀ¸·Î ±âµµÀÇ Æó¼â¸¦ °¡Á®¿À´Â º´À» À̸£´Â ¸». ´ë°³ ¸¸¼º±â°üÁö¿°, ±â°üÁö õ½Ä, Æó±âÁ¾ÀÇ 3°¡Áö º´À» ¸»ÇÑ´Ù. ¸¸¼º±â°üÁö¿°À̶õ ±â°üÁöÀÇ ¸¸¼º¿°ÁõÀ» ¸»ÇÑ´Ù. ±â°üÁöÀÇ ¿°ÁõÀ¸·Î ÀÎÇØ¼ ±â°üÁöÀÇ Á¡¸·¿¡ ºÎÁ¾ÀÌ »ý±â°í ÀÌ·Î ÀÎÇØ¼ ±â°üÁöÀÇ ³»°æÀÌ Á¼¾ÆÁ®¼ ±âµµÀÇ Æó¼â¸¦ °¡Á®¿Â´Ù. ´ë°³ Èí¿¬°ú ¹ÐÁ¢ÇÑ ¿¬°üÀ» °¡Áö¸ç, È£Èí°ï¶õ, ±âħ, ±×¸®°í °¡·¡(´ë°³ »öÀÌ Çª¸£°í Á¡µµ°¡ ³ôÀº °¡·¡)°¡ Áõ»óÀ¸·Î ³ªÅ¸³´Ù. Æó±âÁ¾Àº ±â°üÁöÀÇ º®À» ÁöÁöÇÏ´Â Á¶Á÷ÀÇ ÆÄ±«¿¡ ÀÇÇØ¼ ±â°üÁö°¡ Á¦ ¸ð¾çÀ» °®ÃßÁö ¸øÇÏ°í ¹«³ÊÁö°Ô µÇ¾î ±âµµÀÇ Æó¼â°¡ ÀϾ´Â º´ÀÌ´Ù. Áï ±â°üÁö°¡ °ü ¸ð¾çÀ¸·Î ÆØÆØÇÏ°Ô ÆìÁö´Â °ÍÀ» ÁöÁöÇÏ´Â Á¶Á÷ÀÇ ÆÄ±«¿¡ ÀÇÇØ¼ °ü¸ð¾çÀ¸·Î ÆìÁöÁö ¸øÇØ °á±¹Àº ÆóÆ÷³»¿¡ °ø±â°¡ Â÷°í ÆóÆ÷º®ÀÌ ÆÄ¿µÇ°í ±â°üÁö°¡ Á¼¾ÆÁö°Ô µÇ´Â º´À» ¸»ÇÑ´Ù. ±â°üÁöõ½ÄÀ̶õ ¿©·¯ °¡Áö Àڱؿ¡ ´ëÇØ¼ ±â°üÁö°¡ °ú¹ÎÇÑ ¹ÝÀÀÀ» º¸¿©¼ »ý±â´Â ±â°üÁöÀÇ °¡¿ªÀûÀÎ Æó¼â¸¦ ÀǹÌÇÑ´Ù. Áï Á¤»óÀο¡°Ô¼´Â ±â°üÁöÀÇ Æó¼â¸¦ º¸ÀÌÁö ¾Ê´Â Àڱؿ¡ ´ëÇØ¼ ±â°üÁöÀÇ Æó¼â°¡ »ý±â°í ±× ÀÚ±ØÀÌ ¾øÀ» °æ¿ì¿¡´Â ±â°üÁöÀÇ Æó¼â°¡ ¾ø¾îÁö´Â º´À» ¸»ÇÑ´Ù. |
||
| ¿µ¹® | chronic active hepatitis | ÇÑ±Û | ¸¸¼ºÈ°µ¿°£¿° |
|---|---|---|---|
| ¼³¸í | BÇü °£¿°À̳ª ºñAÇü£ºñBÇü °£¿°ÀÇ ¼Ó¹ßÁõÀ¸·Î ³ªÅ¸³ª´Â °£ÀÇ ¸¸¼º¿°ÁõÀÌ´Ù. °°Àº ÇüÅÂÀÇ º´ÀÌ ¼±Ãµ¼º ¶Ç´Â ÈÄõ°¨¸¶±Û·ÎºÒ¸°°áÇÌÁõÀ̳ª ¾î¶² Á¾·ùÀÇ ¾à¹° Åõ¿©¿¡ ¼ö¹ÝÇØ¼ ³ªÅ¸³¯ ¼öµµ ÀÖ´Ù. Ư¡ÀûÀ¸·Î ¹®¸ÆºÎ¿¡ ÇüÁú¼¼Æ÷¿Í Å«Æ÷½Ä¼¼Æ÷ÀÇ Ä§À±, Á¶°¢±«»ç(°£¼Ò¿± ÁÖº¯ºÎ °£¼¼Æ÷ÀÇ ÆÄ±«) ¹× ¼¶À¯Áõ µîÀÇ Á¶Á÷¼Ò°ßÀ» ³ªÅ¸³½´Ù. º´ÀÇ °æ°ú´Â ¸Å¿ì ´Ù¾çÇϸç Àå±â°£ÀÇ ¹«Áõ»ó±â¸¦ º¸ÀÏ ¼öµµ ÀÖ°í ±× »çÀÌ »çÀÌ¿¡ Ȳ´Þ, Àü½Å¼è¾à, ½Ä¿åºÎÁø ¹× ¹ß¿ µîÀÇ Áõ»óÀÌ ³ªÅ¸³ª´Â ¼ö°¡ ÀÖÀ¸¸ç, ¶Ç ¹«¿ù°æÁõ, °üÀý¿°, ÇǺιßÁø, Ç÷°ü¿°, °©»ó»ù¿°, ÄáÆÏ»ç±¸Ã¼¿°, ±Ë¾ç¼º´ëÀå¿°, ½¦±×·»ÁõÈıº µî °£ ÀÌ¿ÜÀÇ Áõ»óÀÌ ³ªÅ¸³ª´Â ¼öµµ ÀÖ°í, °£°æÈÁõ°ú °£±â´É»ó½Ç·Î ÁøÇàµÇ´Â ¼öµµ ÀÖ´Ù. ÀÚ°¡¸é¿ª¸ÞÄ¿´ÏÁòÀÌ °ü¿©µÇ´Â °ÍÀ¸·Î ÃßÃøµÇ°í ÀÖ´Ù. |
||
| CR | calculation rate; calculus removed; calorie-restricted; cardiac rehabilitation; cardiac resuscitatio... |
|---|---|
| CP | candle power; capillary pressure; cardiac pacing; cardiac performance; cardiopulmonary; caudate puta... |
| CRD | carbohydrate-recognition domain; chronic renal disease; chronic respiratory disease; child restraint... |
| AR | absolute risk; accounts receivable; achievement ratio; actinic reticuloid [syndrome]; active resista... |
| CMR | cardiomodulorespirography; cerebral metabolic rate; chief medical resident; common medical record; c... |
| AR | allograft rejection |
|---|---|
| CADI | Chronic Allograft Damage Index |
| CAN | Chronic allograft nephropathy |
| CR | Chronic rejection |
| AIF-1 | Allograft Inflammatory Factor-1 |
| chronic allograft rejection | Immunologically mediated damage to the allograft, typically a kidney allograft, manifested by diffuse interstitial fibrosis glomerular changes, typically membranous and sclerotic in nature, as well as intimal fibrosis of the blood vessels with tubular atrophy and loss of tubular structures. (05 Mar 2000) |
|---|
| allograft rejection | The rejection of tissue transplanted between two genetically different individuals of the same species. Rejection is caused by T lymphocytes responding to the foreign major histocompatibility complex of the graft. Synonym: homograft. (05 Mar 2000) |
|---|---|
| chronic rejection | A transplant rejection occurring after a few or many months, mainly from persisting serum antibody action. (05 Mar 2000) |
| allograft | <haematology> Grafts between two or more individuals allogeneic at one or more loci (usually with reference to histocompatibility loci). As opposed to autograft and xenograft. (18 Nov 1997) |
| allograft immunity | <immunology> The recipient's immune system rejects tissue grafted from a genetically dissimilar donor (of the same species) and stages an immune attack against it. (09 Oct 1997) |
| accelerated rejection | A transplant rejection manifested in less than three days. (05 Mar 2000) |
| acute cellular rejection | Graft rejection which usually begins within 10 days after a graft has been transplanted into a genetically dissimilar host. Lesions at the site of the graft characteristically are infiltrated with large numbers of lymphocytes and macrophages which cause tissue damage. See: primary rejection. Synonym: acute rejection. (05 Mar 2000) |
| acute kidney transplant rejection | <radiology> Findings on ultrasound: globular enlargment of the kidney, swelling and hypoechogenicity of the medullary pyramids, indistinct cortico-medullary junction, foci in the renal cortex (12 Dec 1998) |
| acute rejection | Graft rejection which usually begins within 10 days after a graft has been transplanted into a genetically dissimilar host. Lesions at the site of the graft characteristically are infiltrated with large numbers of lymphocytes and macrophages which cause tissue damage. See: primary rejection. Synonym: acute rejection. (05 Mar 2000) |
| parental rejection | Withholding of affection from or denial of attention to one's child. Child's withholding of affection from its parent. (05 Mar 2000) |
| rejection | 1. <immunology, surgery> Usually used of grafts. Any process leading to the destruction or detachment of a graft or other specified structure. 2. <psychology> Non-acceptance, negative attitudes, hostility or excessive criticism of the individual which may precipitate feelings of rejection. (12 Dec 1998) |
| graft rejection | <haematology, immunology> When donated bone marrow infused during a bone marrow transplant is rejected by the patients body or does not take. (16 Dec 1997) |
| primary rejection | A rejection occurring more than seven days after transplantation, mainly from a cellular immune response. (05 Mar 2000) |
| second set rejection | An accelerated rejection of a transplant that occurs when an individual has been previously sensitised to the graft. (05 Mar 2000) |
| hyperacute rejection | A rejection that usually develops in less than one hour from the implantation of a vascular graft, a form of antibody-mediated, usually irreversible damage to a transplanted organ, particularly the kidney, manifested predominantly by diffuse thrombotic lesions, usually confined to the organ itself and only rarely disseminated, for skin allograft rejection of this type, see white graft. (05 Mar 2000) |
| first-set rejection | Allograft transplantation between two organisms not previously sensitised to the graft tissue. Necrosis of the graft usually occurs within 10 days of transplantation. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|